{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T10:31:09Z","timestamp":1793442669335,"version":"4.5.0"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003627","name":"Rural Development Administration","doi-asserted-by":"publisher","award":["RS-2026-25518677"],"award-info":[{"award-number":["RS-2026-25518677"]}],"id":[{"id":"10.13039\/501100003627","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/03xs9yg50","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00406114"],"award-info":[{"award-number":["RS-2024-00406114"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/013aysd81","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2025-00517908"],"award-info":[{"award-number":["RS-2025-00517908"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/013aysd81","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jconrel.2026.115359","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:29:48Z","timestamp":1789540188000},"page":"115359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PB","title":["Colon-targeted EGCG delivery remodels the gut microenvironment to enhance therapeutic efficacy in ulcerative colitis"],"prefix":"10.1016","volume":"399","author":[{"given":"Prabhat","family":"Shrestha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongjun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Yun","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Seo","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungchan","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo-Jong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taeg Kyu","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinkyung","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simmyung","family":"Yook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10401","key":"10.1016\/j.jconrel.2026.115359_bb0005","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","article-title":"Ulcerative colitis","volume":"402","author":"Le Berre","year":"2023","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115359_bb0010","doi-asserted-by":"crossref","first-page":"135","DOI":"10.7861\/clinmed.2021-0080","article-title":"Ulcerative colitis: an update","volume":"21","author":"Segal","year":"2021","journal-title":"Clin. Med. (Lond.)"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115359_bb0015","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41575-024-01035-7","article-title":"Understanding the therapeutic toolkit for inflammatory bowel disease","volume":"22","author":"Vieujean","year":"2025","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115359_bb0020","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-020-0205-x","article-title":"Ulcerative colitis","volume":"6","author":"Kobayashi","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115359_bb0025","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.gtc.2020.07.005","article-title":"Epidemiology and pathogenesis of ulcerative colitis","volume":"49","author":"Du","year":"2020","journal-title":"Gastroenterol. Clin."},{"key":"10.1016\/j.jconrel.2026.115359_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118129","article-title":"Ulcerative colitis: gut microbiota, immunopathogenesis and application of natural products in animal models","volume":"258","author":"Nascimento","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.jconrel.2026.115359_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1126579","article-title":"Recent updates on correlation between reactive oxygen species and synbiotics for effective management of ulcerative colitis","volume":"10","author":"Ashique","year":"2023","journal-title":"Front. Nutr."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115359_bb0040","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s40824-023-00412-8","article-title":"Restoration of dysregulated intestinal barrier and inflammatory regulation through synergistically ameliorating hypoxia and scavenging reactive oxygen species using ceria nanozymes in ulcerative colitis","volume":"27","author":"Zhang","year":"2023","journal-title":"Biomater. Res."},{"key":"10.1016\/j.jconrel.2026.115359_bb0045","doi-asserted-by":"crossref","first-page":"1390351","DOI":"10.3389\/fendo.2024.1390351","article-title":"The emerging role of oxidative stress in inflammatory bowel disease","volume":"15","author":"Muro","year":"2024","journal-title":"Front. Endocrinol."},{"issue":"18","key":"10.1016\/j.jconrel.2026.115359_bb0050","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.lfs.2005.12.006","article-title":"Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications","volume":"78","author":"Zaveri","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.jconrel.2026.115359_bb0055","article-title":"Neuroprotective insights into epigallocatechin gallate (EGCG) for neurodegenerative disorders","volume":"4","author":"Kamboj","year":"2025","journal-title":"Explor. Neurosci."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115359_bb0060","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.bcp.2011.07.093","article-title":"Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications","volume":"82","author":"Singh","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115359_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2019.103654","article-title":"Oral administration of green tea polyphenols (TP) improves ileal injury and intestinal flora disorder in mice with Salmonella typhimurium infection via resisting inflammation, enhancing antioxidant action and preserving tight junction","volume":"64","author":"Zhang","year":"2020","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.jconrel.2026.115359_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2021.104743","article-title":"(\u2212)-Epiigallocatechin-3-gallate (EGCG) modulates polarized macrophages to suppress M1 phenotype and promote M2 polarization in vitro and in vivo","volume":"87","author":"Hu","year":"2021","journal-title":"J. Funct. Foods"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115359_bb0075","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3390\/ijms24010340","article-title":"Therapeutic effects of green tea polyphenol (\u2212)-Epigallocatechin-3-Gallate (EGCG) in relation to molecular pathways controlling inflammation, oxidative stress, and apoptosis","volume":"24","author":"Mokra","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115359_bb0080","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1007\/BF02980029","article-title":"Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 activity by 1,2,3,4,6-Penta-O-galloyl-\u03b2-D-glucose in murine macrophage cells","volume":"26","author":"Lee","year":"2003","journal-title":"Arch. Pharm. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115359_bb0085","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s43556-024-00240-9","article-title":"Epigallocatechin-3-gallate therapeutic potential in human diseases: molecular mechanisms and clinical studies","volume":"5","author":"Alam","year":"2024","journal-title":"Mol Biomed"},{"key":"10.1016\/j.jconrel.2026.115359_bb0090","doi-asserted-by":"crossref","first-page":"1078642","DOI":"10.3389\/fnut.2022.1078642","article-title":"Targeting a transcription factor NF-\u03baB by green tea catechins using in silico and in vitro studies in pancreatic cancer","volume":"9","author":"Suhail","year":"2023","journal-title":"Front. Nutr."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115359_bb0095","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/ptr.5061","article-title":"Quercetin and EGCG exhibit chemopreventive effects in cholangiocarcinoma cells via suppression of JAK\/STAT signaling pathway","volume":"28","author":"Senggunprai","year":"2014","journal-title":"Phytother. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115359_bb0100","doi-asserted-by":"crossref","DOI":"10.1186\/s40168-021-01115-9","article-title":"Gut microbiota from green tea polyphenol-dosed mice improves intestinal epithelial homeostasis and ameliorates experimental colitis","volume":"9","author":"Wu","year":"2021","journal-title":"Microbiome"},{"issue":"12","key":"10.1016\/j.jconrel.2026.115359_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.advnut.2025.100545","article-title":"Tea polyphenol epigallocatechin gallate and the gut-health axis: unraveling structural characteristics, metabolic pathways, and systemic benefits","volume":"16","author":"Yang","year":"2025","journal-title":"Adv. Nutr."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115359_bb0110","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1158\/1078-0432.CCR-04-2549","article-title":"Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of polyphenon E in healthy individuals","volume":"11","author":"Chow","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"24","key":"10.1016\/j.jconrel.2026.115359_bb0115","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1021\/jf0519055","article-title":"Stability of tea polyphenol (\u2212)-epigallocatechin-3-gallate and formation of dimers and epimers under common experimental conditions","volume":"53","author":"Sang","year":"2005","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.jconrel.2026.115359_bb0120","doi-asserted-by":"crossref","first-page":"573297","DOI":"10.3389\/fchem.2020.573297","article-title":"Advanced nanovehicles-enabled delivery systems of epigallocatechin gallate for cancer therapy","volume":"8","author":"Li","year":"2020","journal-title":"Front. Chem."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115359_bb0125","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ijpharm.2016.12.030","article-title":"Cancer therapeutics with epigallocatechin-3-gallate encapsulated in biopolymeric nanoparticles","volume":"518","author":"Tyagi","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115359_bb0130","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s40005-025-00725-x","article-title":"Enhanced cellular uptake of sorafenib for hepatocellular carcinoma treatment: surface-modified PLGA nanoparticles with biomimetic alterations","volume":"55","author":"Jin","year":"2025","journal-title":"J. Pharm. Investig."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115359_bb0135","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s40005-023-00657-4","article-title":"Transferrin modified PEG\u2013PLGA nanoparticles: highly effective notoginsenoside R1 formulations for the treatment of ulcerative colitis","volume":"54","author":"Zhou","year":"2024","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.jconrel.2026.115359_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2024.112983","article-title":"Advances in chitosan-based drug delivery systems: a comprehensive review for therapeutic applications","volume":"210","author":"Haider","year":"2024","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.jconrel.2026.115359_bb0145","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jconrel.2022.10.005","article-title":"Chitosan on the surface of nanoparticles for enhanced drug delivery: a comprehensive review","volume":"351","author":"Elkomy","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115359_bb0150","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejpb.2018.06.011","article-title":"Chitosan-coated liposome dry-powder formulations loaded with ghrelin for nose-to-brain delivery","volume":"129","author":"Salade","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"11","key":"10.1016\/j.jconrel.2026.115359_bb0155","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1039\/D2MA00295G","article-title":"Oral drug delivery using a polymeric nanocarrier: chitosan nanoparticles in the delivery of rifampicin","volume":"3","author":"Ghosh","year":"2022","journal-title":"Mater. Adv."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115359_bb0160","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/10717540590889781","article-title":"Chitosan-based particles as controlled drug delivery systems","volume":"12","author":"Prabaharan","year":"2004","journal-title":"Drug Deliv."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115359_bb0165","article-title":"Advances in the development of amorphous solid dispersions: the role of polymeric carriers","volume":"18","author":"Zhang","year":"2023","journal-title":"Asian J. Pharmaceut. Sci."},{"key":"10.1016\/j.jconrel.2026.115359_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2025.107578","article-title":"Development of pH responsive drug delivery system for antichagasic benznidazole using clay-based laponite carrier coated with Eudragit\u00ae S100","volume":"114","author":"Batista","year":"2025","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.jconrel.2026.115359_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2024.106234","article-title":"Eudragit S100 coated surfactant vesicles for boosted oral bioavailability of ticagrelor","volume":"101","author":"Marei","year":"2024","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.jconrel.2026.115359_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2024.113849","article-title":"Eudragit S100 coated nanodiamond-based nanoparticles as an oral chemo-photothermal delivery system for local treatment of colon cancer","volume":"237","author":"Su","year":"2024","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2026.115359_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111582","article-title":"Enteric-coated gelatin nanoparticles mediated oral delivery of 5-aminosalicylic acid alleviates severity of DSS-induced ulcerative colitis","volume":"119","author":"Ahmad","year":"2021","journal-title":"Mater. Sci. Eng. C"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115359_bb0190","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/nu14010137","article-title":"Polyphenols\u2014gut microbiota interrelationship: a transition to a new generation of prebiotics","volume":"14","author":"Plamada","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.jconrel.2026.115359_bb0195","article-title":"Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases","volume":"10","author":"Parada Venegas","year":"2019","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115359_bb0200","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1093\/ecco-jcc\/jjad052","article-title":"Multiomics-empowered deep phenotyping of ulcerative colitis identifies biomarker signatures reporting functional remission states","volume":"17","author":"Janker","year":"2023","journal-title":"J. Crohn\u2019s Colitis"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115359_bb0205","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.7150\/ijbs.67112","article-title":"Lipidomic trajectories characterize delayed mucosal wound healing in quiescent ulcerative colitis and identify potential novel therapeutic targets","volume":"18","author":"Bjerrum","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.jconrel.2026.115359_bb0210","article-title":"Investigating intestinal inflammation in DSS-induced model of IBD","volume":"60","author":"Kim","year":"2012","journal-title":"J. Visualiz. Exp. JoVE"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115359_bb0215","article-title":"Modulation of gut barrier functions in ulcerative colitis by hyaluronic acid system","volume":"9","author":"Kotla","year":"2022","journal-title":"Adv Sci (Weinh)"},{"issue":"32","key":"10.1016\/j.jconrel.2026.115359_bb0220","doi-asserted-by":"crossref","first-page":"13098","DOI":"10.1073\/pnas.0702440104","article-title":"LRH-1-mediated glucocorticoid synthesis in enterocytes protects against inflammatory bowel disease","volume":"104","author":"Coste","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.115359_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1610435","article-title":"Immune dysregulation in ulcerative colitis: pathogenic mechanisms and therapeutic strategies of traditional Chinese medicine","volume":"13","author":"Tang","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jconrel.2026.115359_bb0230","doi-asserted-by":"crossref","first-page":"1623491","DOI":"10.3389\/fimmu.2025.1623491","article-title":"Macrophages: emerging targets for ulcerative colitis","volume":"16","author":"Chen","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115359_bb0235","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s43556-024-00207-w","article-title":"Ulcerative colitis: molecular insights and intervention therapy","volume":"5","author":"Liang","year":"2024","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.jconrel.2026.115359_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155408","article-title":"Therapeutic effects of epigallocatechin-3-gallate for inflammatory bowel disease: a preclinical meta-analysis","volume":"128","author":"Wei","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jconrel.2026.115359_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jnutbio.2016.01.002","article-title":"Stability of (\u2212)-epigallocatechin gallate and its activity in liquid formulations and delivery systems","volume":"37","author":"Krupkova","year":"2016","journal-title":"J. Nutr. Biochem."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115359_bb0250","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.3390\/ijms12095592","article-title":"Epigallocatechin-3-gallate (EGCG) for clinical trials: more pitfalls than promises?","volume":"12","author":"Mereles","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115359_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/molecules31020287","article-title":"Recent insights into protein-polyphenol complexes: molecular mechanisms, processing technologies, synergistic bioactivities, and food applications","volume":"31","author":"Huynh","year":"2026","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2026.115359_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodhyd.2025.111590","article-title":"Protein-polyphenol complexation vs. conjugation: a review on mechanisms, functional differences, and antioxidant-emulsifier roles","volume":"169","author":"Ebrahimi","year":"2025","journal-title":"Food Hydrocoll."},{"key":"10.1016\/j.jconrel.2026.115359_bb0265","first-page":"703","article-title":"Chitosan based smart injectable hydrogels for biomedical applications: a comprehensive review","volume":"55","author":"Salamat","year":"2026","journal-title":"Bioact. Mater."},{"issue":"44","key":"10.1016\/j.jconrel.2026.115359_bb0270","doi-asserted-by":"crossref","first-page":"21125","DOI":"10.1021\/acsanm.5c03463","article-title":"Review of chitosan-coated nanoscale liposomes for enhanced drug delivery","volume":"8","author":"Alcantara","year":"2025","journal-title":"ACS Appl. Nano Mater."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115359_bb0275","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12929-025-01161-7","article-title":"Chitosan-based formulations for therapeutic applications. A recent overview","volume":"32","author":"Gonciarz","year":"2025","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.jconrel.2026.115359_bb0280","doi-asserted-by":"crossref","first-page":"102358","DOI":"10.1016\/j.mtbio.2025.102358","article-title":"Chitosan nanoparticles: green synthesis, biological activities, and sustainable frontiers in targeted drug delivery and cancer nanomedicine \u2013 a comprehensive review","volume":"35","author":"El-Saadony","year":"2025","journal-title":"Mater. Today Bio"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115359_bb0285","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0168-3659(98)00151-5","article-title":"A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers: I. Manipulation of drug release using Eudragit\u00ae L100-55 and Eudragit\u00ae S100 combinations","volume":"58","author":"Khan","year":"1999","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115359_bb0290","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12951-020-00662-x","article-title":"Enhanced oral delivery of insulin via the colon-targeted nanocomposite system of organoclay\/glycol chitosan\/Eudragit\u00aeS100","volume":"18","author":"Lee","year":"2020","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.115359_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.supflu.2025.106753","article-title":"Preparation of 5-ASA-loaded Eudragit\u00ae S100 nanoparticles by emulsion-based methods: comparison between solvent evaporation and supercritical fluid extraction","volume":"227","author":"Vizcaya","year":"2026","journal-title":"J. Supercrit. Fluids"},{"key":"10.1016\/j.jconrel.2026.115359_bb0300","doi-asserted-by":"crossref","first-page":"5813793","DOI":"10.1155\/2017\/5813793","article-title":"Therapeutic potential of epigallocatechin gallate nanodelivery systems","volume":"2017","author":"Granja","year":"2017","journal-title":"Biomed. Res. Int."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115359_bb0305","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23020445","article-title":"Food-grade encapsulation systems for (\u2212)-epigallocatechin gallate","volume":"23","author":"Shi","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2026.115359_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.137463","article-title":"Design strategies of polysaccharide, protein and lipid-based nano-delivery systems in improving the bioavailability of polyphenols and regulating gut homeostasis","volume":"283","author":"Guo","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115359_bb0315","doi-asserted-by":"crossref","first-page":"188","DOI":"10.5009\/gnl.2012.6.2.188","article-title":"Epigallocatechin-3-gallate inhibits LPS-induced NF-\u03baB and MAPK signaling pathways in bone marrow-derived macrophages","volume":"6","author":"Joo","year":"2012","journal-title":"Gut Liver"},{"key":"10.1016\/j.jconrel.2026.115359_bb0320","article-title":"Epigallocatechin gallate suppresses inflammation in human coronary artery endothelial cells by inhibiting NF-\u03baB","volume":"258","author":"Reddy","year":"2020","journal-title":"Life Sci."},{"issue":"8","key":"10.1016\/j.jconrel.2026.115359_bb0325","article-title":"Green tea polyphenol (\u2212)-Epigallocatechin-3-Gallate (EGCG): a time for a new player in the treatment of respiratory diseases?","volume":"11","author":"Mokra","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.jconrel.2026.115359_bb0330","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jare.2023.12.004","article-title":"Biological potential and mechanisms of tea\u2019s bioactive compounds: an updated review","volume":"65","author":"Luo","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.jconrel.2026.115359_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107412","article-title":"Epigallocatechin-3-gallate prevents inflammation and diabetes -induced glucose tolerance through inhibition of NLRP3 inflammasome activation","volume":"93","author":"Zhang","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2026.115359_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108170","article-title":"Epigallocatechin gallate (EGCG) attenuates staphylococcal alpha-hemolysin (Hla)-induced NLRP3 inflammasome activation via ROS-MAPK pathways and EGCG-Hla interactions","volume":"100","author":"Liu","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115359_bb0345","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/1462-2920.13589","article-title":"Formation of propionate and butyrate by the human colonic microbiota","volume":"19","author":"Louis","year":"2017","journal-title":"Environ. Microbiol."},{"issue":"7331","key":"10.1016\/j.jconrel.2026.115359_bb0350","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature09646","article-title":"Bifidobacteria can protect from enteropathogenic infection through production of acetate","volume":"469","author":"Fukuda","year":"2011","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115359_bb0355","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1365-2036.2007.03562.x","article-title":"The role of butyrate on colonic function","volume":"27","author":"Hamer","year":"2008","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"6145","key":"10.1016\/j.jconrel.2026.115359_bb0360","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1126\/science.1241165","article-title":"The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis","volume":"341","author":"Smith","year":"2013","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115359_bb0365","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1038\/s41467-018-05470-4","article-title":"Microbial tryptophan catabolites in health and disease","volume":"9","author":"Roager","year":"2018","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115359_bb0370","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/gutjnl-2022-327337","article-title":"Rewiring the altered tryptophan metabolism as a novel therapeutic strategy in inflammatory bowel diseases","volume":"72","author":"Michaudel","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2026.115359_bb0375","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01957","article-title":"Kynurenic acid: the Janus-faced role of an immunomodulatory tryptophan metabolite and its link to pathological conditions","volume":"8","author":"Wirthgen","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115359_bb0380","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/1484806","article-title":"5-Methoxytryptophan alleviates dextran sulfate sodium-induced colitis by inhibiting the intestinal epithelial damage and inflammatory response","volume":"2024","author":"Wang","year":"2024","journal-title":"Mediat. Inflamm."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115359_bb0385","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1423-0127-21-17","article-title":"5-methoxyindole metabolites of L-tryptophan: control of COX-2 expression, inflammation and tumorigenesis","volume":"21","author":"Wu","year":"2014","journal-title":"J. Biomed. Sci."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115359_bb0390","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.immuni.2013.08.003","article-title":"Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via Interleukin-22","volume":"39","author":"Zelante","year":"2013","journal-title":"Immunity"},{"issue":"32","key":"10.1016\/j.jconrel.2026.115359_bb0395","doi-asserted-by":"crossref","first-page":"19376","DOI":"10.1073\/pnas.2000047117","article-title":"Microbial tryptophan metabolites regulate gut barrier function via the aryl hydrocarbon receptor","volume":"117","author":"Scott","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115359_bb0400","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41392-025-02500-8","article-title":"The aryl hydrocarbon receptor: structure, signaling, physiology and pathology","volume":"11","author":"Coumoul","year":"2026","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115359_bb0405","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.3389\/fmicb.2018.01736","article-title":"Dietary L-tryptophan modulates the structural and functional composition of the intestinal microbiome in weaned piglets","volume":"9","author":"Liang","year":"2018","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115359_bb0410","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/gut.40.1.95","article-title":"Gene expression of group II phospholipase A2 in intestine in ulcerative colitis","volume":"40","author":"Haapam\u00e4ki","year":"1997","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115359_bb0415","first-page":"65","article-title":"Role of nitric oxide-synthase and cyclooxygenase\/lipooxygenase systems in development of experimental ulcerative colitis","volume":"62","author":"Ya Sklyarov","year":"2011","journal-title":"J. Physiol. Pharmacol."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115359_bb0420","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/ibd.20094","article-title":"Colonic expression of leukotriene-pathway enzymes in inflammatory bowel diseases","volume":"13","author":"Jupp","year":"2007","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.jconrel.2026.115359_bb0425","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.prostaglandins.2015.04.002","article-title":"Effect of acute and chronic DSS induced colitis on plasma eicosanoid and oxylipin levels in the rat","volume":"120","author":"Willenberg","year":"2015","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115359_bb0430","doi-asserted-by":"crossref","first-page":"5","DOI":"10.15252\/embj.201694660","article-title":"Prostaglandin E2 promotes intestinal repair through an adaptive cellular response of the epithelium","volume":"36","author":"Miyoshi","year":"2017","journal-title":"EMBO J."},{"key":"10.1016\/j.jconrel.2026.115359_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2023.149411","article-title":"Berberine alleviates inflammation and suppresses PLA2-COX-2-PGE2-EP2 pathway through targeting gut microbiota in DSS-induced ulcerative colitis","volume":"695","author":"Yu","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115359_bb0440","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/ijc.20629","article-title":"Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells","volume":"113","author":"Hussain","year":"2005","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115359_bb0445","doi-asserted-by":"crossref","DOI":"10.3390\/nu17030547","article-title":"EGCG alleviates DSS-induced colitis by inhibiting ferroptosis through the activation of the Nrf2-GPX4 pathway and enhancing iron metabolism","volume":"17","author":"Chen","year":"2025","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115359_bb0450","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/jgh3.12212","article-title":"Causation of human ulcerative colitis: a lead from an animal model that mirrors human disease","volume":"3","author":"Roediger","year":"2019","journal-title":"JGH Open"},{"key":"10.1016\/j.jconrel.2026.115359_bb0455","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jare.2025.12.007","article-title":"c-Myc-PANK3-EMT axis regulates the structure and function of intestinal barrier in ulcerative colitis","volume":"87","author":"Zhang","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.jconrel.2026.115359_bb0460","doi-asserted-by":"crossref","DOI":"10.1093\/femsre\/fuaf051","article-title":"Coenzyme a metabolism: a key driver of gut microbiota dynamics and metabolic profiles","volume":"49","author":"B\u00f6ttcher","year":"2025","journal-title":"FEMS Microbiol. Rev."},{"issue":"22","key":"10.1016\/j.jconrel.2026.115359_bb0465","doi-asserted-by":"crossref","first-page":"10623","DOI":"10.1158\/0008-5472.CAN-05-1949","article-title":"Inhibition of intestinal tumorigenesis in Apc min\/+ mice by (\u2212)-epigallocatechin-3-gallate, the major catechin in green tea","volume":"65","author":"Ju","year":"2005","journal-title":"Cancer Res."},{"issue":"24","key":"10.1016\/j.jconrel.2026.115359_bb0470","doi-asserted-by":"crossref","first-page":"17008","DOI":"10.1039\/D4RA02598A","article-title":"Medium-chain dicarboxylic acids: chemistry, pharmacological properties, and applications in modern pharmaceutical and cosmetics industries","volume":"14","author":"Liao","year":"2024","journal-title":"RSC Adv."},{"issue":"11","key":"10.1016\/j.jconrel.2026.115359_bb0475","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/jgh.12966","article-title":"Expression of hepatic cytochrome P 450 in a mouse model of ulcerative colitis changes with pathological conditions","volume":"30","author":"Kusunoki","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115359_bb0480","doi-asserted-by":"crossref","DOI":"10.3390\/metabo16010045","article-title":"A comprehensive review on medium-and long-chain fatty acid-derived metabolites: from energy sources to metabolic signals","volume":"16","author":"Park","year":"2026","journal-title":"Metabolites"},{"issue":"17","key":"10.1016\/j.jconrel.2026.115359_bb0485","doi-asserted-by":"crossref","first-page":"15217","DOI":"10.1021\/acsomega.3c00210","article-title":"Azelaic acid regulates the renin\u2013angiotensin system and improves colitis based on network pharmacology and experimentation","volume":"8","author":"Liao","year":"2023","journal-title":"ACS Omega"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115359_bb0490","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41538-025-00604-7","article-title":"Stachyose attenuates DSS-induced colitis and is associated with elevated colonic medium-chain fatty acids: an integrated multi-omics analysis","volume":"9","author":"Kim","year":"2025","journal-title":"npj Sci. Food"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115359_bb0495","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites","volume":"165","author":"Koh","year":"2016","journal-title":"Cell"},{"issue":"7480","key":"10.1016\/j.jconrel.2026.115359_bb0500","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature12721","article-title":"Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells","volume":"504","author":"Furusawa","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115359_bb0505","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1111\/jgh.15970","article-title":"Short\u2010chain fatty acids affect the development of inflammatory bowel disease through intestinal barrier, immunology, and microbiota: a promising therapy?","volume":"37","author":"Peng","year":"2022","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115359_bb0510","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.bbrc.2007.03.025","article-title":"The short chain fatty acid, butyrate, stimulates MUC2 mucin production in the human colon cancer cell line, LS174T","volume":"356","author":"Hatayama","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115359_bb0515","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cmet.2011.02.018","article-title":"The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon","volume":"13","author":"Donohoe","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.jconrel.2026.115359_bb0520","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.02259","article-title":"Administration of Akkermansia muciniphila ameliorates dextran sulfate sodium-induced ulcerative colitis in mice","volume":"10","author":"Bian","year":"2019","journal-title":"Front. Microbiol."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115359_bb0525","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00770-17","article-title":"Microbial metabolic networks at the mucus layer lead to diet-independent butyrate and vitamin B12 production by intestinal symbionts","volume":"8","author":"Belzer","year":"2017","journal-title":"MBio"},{"key":"10.1016\/j.jconrel.2026.115359_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2025.128317","article-title":"Akkermansia muciniphila: a key player in gut microbiota-based disease modulation","volume":"301","author":"Shaheen","year":"2025","journal-title":"Microbiol. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115359_bb0535","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1186\/s12967-025-07149-z","article-title":"Akkermansia muciniphila: a microbial guardian against oxidative stress\u2013gut microbiota crosstalk and clinical prospects","volume":"23","author":"Ye","year":"2025","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115359_bb0540","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41579-024-01106-1","article-title":"Akkermansia muciniphila: biology, microbial ecology, host interactions and therapeutic potential","volume":"23","author":"Ioannou","year":"2025","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115359_bb0545","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1038\/s41467-023-39403-7","article-title":"Gut microbiota Turicibacter strains differentially modify bile acids and host lipids","volume":"14","author":"Lynch","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115359_bb0550","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.00292-26","article-title":"Turicibacter sanguinis is a candidate gut microbial pathobiont that promotes metabolic dysfunction-associated steatohepatitis","volume":"11","author":"Guo","year":"2026","journal-title":"mSystems"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115359_bb0555","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1039\/D5FO05003K","article-title":"The therapeutic mechanism of bornyl acetate in alleviating ulcerative colitis by regulating the intestinal flora","volume":"17","author":"Shang","year":"2026","journal-title":"Food Funct."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926007637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926007637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T09:42:33Z","timestamp":1793439753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926007637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":111,"alternative-id":["S0168365926007637"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115359","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Colon-targeted EGCG delivery remodels the gut microenvironment to enhance therapeutic efficacy in ulcerative colitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115359","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115359"}}